The global epidemiology of hypertension

KT Mills, A Stefanescu, J He - Nature Reviews Nephrology, 2020 - nature.com
Hypertension is the leading cause of cardiovascular disease and premature death
worldwide. Owing to the widespread use of antihypertensive medications, global mean …

Rare disease emerging as a global public health priority

CCY Chung, Hong Kong Genome Project… - Frontiers in public …, 2022 - frontiersin.org
The genomics revolution over the past three decades has led to great strides in rare disease
(RD) research, which presents a major shift in global policy landscape. While RDs are …

[BOG][B] WHO report on cancer: setting priorities, investing wisely and providing care for all

World Health Organization - 2020 - books.google.com
Page 1 together 凉 頭 K 湯 WHO REPORT ON CANCER SETTING PRIORITIES, INVESTING WISELY
AND PROVIDING CARE FOR ALL 2020 World Health Organization Page 2 WHO report on cancer …

The economic burden of adults with major depressive disorder in the United States (2019)

P Greenberg, A Chitnis, D Louie, E Suthoff… - Advances in …, 2023 - Springer
Introduction Previous societal burden estimations for major depressive disorder (MDD) often
fail to account for several hidden cost components. This study provides a comprehensive …

Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific …

P Anderson, V Higgins, J Courcy… - Current Medical …, 2023 - Taylor & Francis
Objective To update on and describe the role of Disease Specific Programmes (DSPs), a
multi-perspective real-world data (RWD) source, in the context of the evolution of the value …

[HTML][HTML] Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access

N Ahmed, M Shahzad, E Shippey, R Bansal… - … and Cellular Therapy, 2022 - Elsevier
Chimeric antigen receptor (CAR) T cell therapy is changing the paradigm in hematologic
malignancies, but disparities in access exist in the real-world setting. Efforts to address and …

Cost-effectiveness of aducanumab and donanemab for early Alzheimer disease in the US

EL Ross, MS Weinberg, SE Arnold - JAMA neurology, 2022 - jamanetwork.com
Importance Several anti–amyloid monoclonal antibodies have been developed for slowing
the progression of Alzheimer disease (AD). Among the furthest developed are aducanumab …

[HTML][HTML] The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform …

M Kohli, M Maschio, D Becker, MC Weinstein - Vaccine, 2021 - Elsevier
Background Researchers are working at unprecedented speed to develop a SARS-CoV-2
vaccine. We aimed to assess the value of a hypothetical vaccine and its potential public …

[HTML][HTML] An overview of value, perspective, and decision context—a health economics approach: an ISPOR Special Task Force report [2]

LP Garrison Jr, MV Pauly, RJ Willke, PJ Neumann - Value in health, 2018 - Elsevier
The second section of our Special Task Force builds on the discussion of value and
perspective in the previous article of the report by 1) defining a health economics approach …

[HTML][HTML] Being precise about precision medicine: what should value frameworks incorporate to address precision medicine? A report of the personalized precision …

E Faulkner, AP Holtorf, CY Liu, H Lin, E Biltaj, D Brixner… - Value in Health, 2020 - Elsevier
Precision medicine is a dynamic area embracing a diverse and increasing type of
approaches that allow the targeting of new medicines, screening programs or preventive …